The rise in exclusive deals between insurers and pharmacies
The Decibel
00:00
Introduction
The chapter delves into the controversy surrounding Manulife's decision to alter its coverage plans for specialty care drugs, highlighting the impact on patients with chronic illnesses. The episode details the public backlash, political influence, and eventual reversal of the exclusive deal that restricted patient choice of pharmacies.
Transcript
Play full episode
